Mar 8, 2022 10:08AM Needham & Company Reiterates Revance Therapeutic (RVNC) at Buy, BLA Resubmission Timing is a Welcome Surprise, RVNC Remains Conviction List Top Pick

Mar 1, 2022 06:52AM Needham & Company Reiterates Revance Therapeutic (RVNC) at Buy, Names Conviction List Pick, Sees Daxi BLA Resubmission as Positive

Jan 10, 2022 06:40AM Revance Therapeutics' (RVNC) Remains on Track to Submit Daxi BLA in 1H22 and get New PDUFA in 2H22 - Needham

Oct 18, 2021 06:41AM Revance Therapeutic (RVNC) PT Lowered to $25 at Needham & Company

Oct 13, 2021 05:23AM Revance Therapeutic (RVNC): No Change to Expectations for FDA Approval by Year-End - Needham & Company

Apr 6, 2021 04:05PM Revance to Participate in the 20th Annual Needham Virtual Healthcare Conference

Dec 29, 2020 08:26AM Collegium Pharmaceutical (COLL) Added to Conviction List at Needham on Diversifying Revenue Base

Oct 15, 2020 07:34AM Revance Therapeutic (RVNC) PT Raised to $42 at Needham & Company After Daxi Met All Ph3 Endpoints

Apr 7, 2020 04:05PM Revance to Participate in the 19th Annual Needham Virtual Healthcare Conference

Mar 20, 2020 07:12AM Companies with NDRs 3/20

Mar 19, 2020 06:44AM Companies with NDRs 3/19

Dec 4, 2019 07:42AM Revance Therapeutics (RVNC) Prices 6.5M Share Offering at $17/Sh

Dec 4, 2019 07:41AM Revance Announces Pricing of Public Offering of Common Stock

Aug 27, 2019 12:00PM Revance Therapeutics (RVNC) Falls Modeslty on Amended Mylan (MYL) Botox Biosimilar Deal

May 9, 2019 12:07PM Revance Therapeutic (RVNC) PT Lowered to $32 at Needham & Company

Apr 2, 2019 04:05PM Revance to Participate in the Needham Healthcare Conference

Mar 27, 2018 09:01AM Pre-Open Movers 03/27: (ATRS) (PETX) (RHT) Higher; (LFIN) (GERN) (OSTK) Lower (more...)

Mar 26, 2018 04:22PM Needham & Company Starts Revance Therapeutic (RVNC) at Buy

Mar 20, 2018 04:05PM Revance to Participate in the Needham Healthcare Conference